Taysha Gene Therapies Inc banner

Taysha Gene Therapies Inc
NASDAQ:TSHA

Watchlist Manager
Taysha Gene Therapies Inc Logo
Taysha Gene Therapies Inc
NASDAQ:TSHA
Watchlist
Price: 4.07 USD -5.79% Market Closed
Market Cap: $1.1B

Intrinsic Value

The intrinsic value of one TSHA stock under the Base Case scenario is 1.56 USD. Compared to the current market price of 4.07 USD, Taysha Gene Therapies Inc is Overvalued by 62%.

TSHA Intrinsic Value
1.56 USD
Overvaluation 62%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $1.25
Get notified when the price drops into your buy zone
Current Price $4.07
Intrinsic Value $1.56
Margin of Safety 20% $1.25
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about TSHA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TSHA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Taysha Gene Therapies Inc.

Explain Valuation
Alternatives to TSHA

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Taysha Gene Therapies Inc

Wall St
Price Targets

Dividends

Taysha Gene Therapies Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

TSHA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TSHA stock?

The intrinsic value of one TSHA stock under the Base Case scenario is 1.56 USD.

Is TSHA stock undervalued or overvalued?

Compared to the current market price of 4.07 USD, Taysha Gene Therapies Inc is Overvalued by 62%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett